FNY Investment Advisers’s OncoSec Medical Incorporated ONCS Stock Holding History

FNY Investment Advisers’s Portfolio ONCS Stock Details ONCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-105,690	Closed	-$272K	–	784
2023 Q1	$272K	Buy	+105,690	New	+$210K	0.31%	56

FNY Investment Advisers's ONCS Position: Q2 2023 in Review

FNY Investment Advisers sold out of OncoSec Medical Incorporated (ONCS) in Q2 2023, closing a stake of 105,690 shares — an estimated $272K sold.

FNY Investment Advisers first reported a position in ONCS in Q1 2023 and held it in 1 quarter. The position peaked at $272K in Q1 2023. 0 funds tracked by Wall St. Rank hold ONCS as of Q2 2023.

FNY Investment Advisers reported no remaining OncoSec Medical Incorporated position as of Q2 2023 after selling out during the quarter.
FNY Investment Advisers sold 105,690 OncoSec Medical Incorporated shares in Q2 2023, an estimated $272K.
FNY Investment Advisers first reported a position in OncoSec Medical Incorporated in Q1 2023 and held it in 1 quarter.
FNY Investment Advisers's OncoSec Medical Incorporated position peaked at $272K in Q1 2023.
0 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q2 2023.

Based on FNY Investment Advisers's 13F filing for Q2 2023, filed 11 Jul 2023.